Clinical trial Recruiting at 1 site Interventional Ages 4 to 65

Spinal Stimulation During Walking to See If Spasticity Lessens in Cerebral Palsy

Official title: Acute Effects of Transcutaneous Spinal Stimulation on Spasticity and Gait in Cerebral Palsy

Run by University of Washington · NCT07826494 · Data updated 2026-11-12

This study tests whether walking with non-invasive spinal stimulation reduces leg muscle tightness and improves walking in children and young adults with cerebral palsy.

Quick facts

Study typeInterventional
Ages4 Years to 65 Years
SexAll
Enrollment20 (estimated)
SponsorUniversity of Washington
Academic / other
Locations1 site (Seattle, Washington)
StatusRecruiting
StartedAugust 13, 2026
Main results expectedJune 1, 2028
Study endsDecember 1, 2028
Registry record updatedSeptember 17, 2026
Trial IDNCT07826494 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are 4–65 years old with spastic cerebral palsy, GMFCS levels I–III, and the ability to walk at least 10 minutes.

Probably not a fit

Participants with non-spastic CP, lower functional levels than GMFCS I–III, recent lower-extremity surgery, or contraindications to stimulation may not experience benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers will examine the immediate effects of transcutaneous spinal stimulation during treadmill walking in people with cerebral palsy. Each participant will complete two in-lab visits: one with spinal stimulation while walking and one with walking only. A combination of biomechanical measurements and clinician assessments will be used to gauge spasticity and gait, including step length and gait deviation. The stimulation is delivered using the SCiP device with specific parameters, tailored to each person’s comfort limits. The goal is to determine whether acute spinal stimulation can enhance walking performance and reduce spasticity compared with walking without stimulation.

Why it matters

Potential benefit: If successful, participants may experience lower leg stiffness during walking and better walking quality after an acute stimulation session.

How similar studies have gone: Prior research has shown reduced spasticity with walking plus spinal stimulation, supporting further exploration in CP.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Individuals who:

* have a diagnosis of spastic cerebral palsy or high likelihood of CP diagnosis
* are 4-65 years of age
* have spasticity in lower-extremity muscles
* are at a functional Gross Motor Function Classification System (GMFCS) Level I-III
* can walk for at least 10 minutes with/without support
* can understand and follow simple directions
* have a stable medical condition, as reported by the caregiver/parent

Exclusion Criteria:

Individuals who:

* who have had lower-extremity surgery or injury in the prior 12 months
* have had botulinum toxin injections in the prior 3 months
* have had selective dorsal rhizotomy (SDR) in the past
* have uncontrolled seizures
* have significant cardiovascular or musculoskeletal disease that would prevent full participation
* are dependent on ventilation support
* have implanted stimulator (e.g. epidural stimulator, vagus nerve stimulator, pacemaker, cochlear implant, etc) or drug delivery device (e.g. baclofen pump)
* have established osteoporosis and taking medication for osteoporosis treatment.
* have rheumatic diseases (rheumatoid arthritis, systemic lupus erythematosus, etc.)
* have active cancer
* have received stem cell injections into the spinal cord

Where it's running

  • University of Washington
    Seattle, Washington, United States
    Recruiting

Study contacts

  • Principal investigator: Katherine Steele, PhD — University of Washington
  • Study coordinator: Katherine Steele, PhD
  • Email: kmsteele@uw.edu
  • Phone: 206-685-2390

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.